Sugi Predict

Sugi Predict / Compounds / SCHEMBL1799704

SCHEMBL1799704

SCHEMBL1799704

CCOc1ccccc1C1(OC(=O)N2CCN(C3CCN(C)CC3)CC2)C(=O)N(S(=O)(=O)c2ccccc2OC)c2ccc(C(C)C)cc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AVPR1B P47901 2/20 0.37
▸ ALDH1A1 P00352 5/20 0.37
▸ KMT2A Q03164 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ SMN1; SMN2 Q16637 4/20 0.35
▸ KDM4E B2RXH2 4/20 0.35
▸ LMNA P02545 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ FGFR3 P22607 2/20 0.35
▸ KDR P35968 2/20 0.35
▸ FGFR1 P11362 1/20 0.35
▸ FGFR2 P21802 1/20 0.35
▸ FGFR4 P22455 1/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ TSHR P16473 2/20 0.34
▸ GAA P10253 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1795911 0.95 AVPR1B (0.43) AVPR1BALDH1A1KDM4EAVPR1A
SCHEMBL1800715 0.93 ALDH1A1 (0.38) ALDH1A1KMT2AMEN1SMN1; SMN2KDM4E
SCHEMBL1797306 0.92 ALDH1A1 (0.42) AVPR1BALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL1795581 0.91 AVPR1B (0.38) AVPR1BALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL1796895 0.91 AVPR1B (0.43) AVPR1BALDH1A1KDM4EAVPR1AAPP
SCHEMBL1795556 0.91 AVPR1B (0.43) AVPR1BALDH1A1KMT2ASMN1; SMN2KDM4E
SCHEMBL1796883 0.89 AVPR1B (0.48) AVPR1B
SCHEMBL1794824 0.89 AVPR1B (0.43) AVPR1BALDH1A1SMN1; SMN2KDM4ELMNA
Hydrochloric Acid SCHEMBL1794296 0.88 AVPR1B (0.46) AVPR1BALDH1A1AVPR1A
SCHEMBL1794899 0.88 AVPR1B (0.43) AVPR1BALDH1A1KMT2ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8338590-B2 Substituted oxindole derivatives and medicaments containing the same ABBOTT GMBH & CO. KG (DE) 2012-12-25 — — US disclosed
US-20110257194-A1 SUBSTITUTED OXINDOL DERIVATIVES AND MEDICAMENTS CONTAINING THE SAME ABBOTT GMBH & CO. KG (DE) 2011-10-20 — — US disclosed
US-7951807-B2 Substituted oxindol derivatives and medicaments containing the same ABBOTT GMBH & CO. KG (DE) 2011-05-31 — — US disclosed
US-20090005397-A1 Substituted Oxindol Derivatives and Medicaments Containing the Same ABBVIE DEUTSCHLAND GMBH & CO KG (DE) 2009-01-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005397-A1 Substituted Oxindol Derivatives and Medicaments Containing the Same OXTR, AVPR2, AVPR1B AVPR1B 3/4885ALDH1A1 917/4885KMT2A 4350/4885
US-20110257194-A1 SUBSTITUTED OXINDOL DERIVATIVES AND MEDICAMENTS CONTAINING THE SAME OXTR, AVPR2, AVPR1B AVPR1B 3/4885ALDH1A1 814/4885KMT2A 4284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.